Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 48: 1170-1177, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macgregor, P. F.
Right arrow Articles by Squire, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macgregor, P. F.
Right arrow Articles by Squire, J. A.
Related Collections
Right arrow Cancer Diagnostics (since 2002)
(Clinical Chemistry. 2002;48:1170-1177.)
© 2002 American Association for Clinical Chemistry, Inc.


Reviews

Application of Microarrays to the Analysis of Gene Expression in Cancer

Pascale F. Macgregor1 and Jeremy A. Squire2,3,4a

1 Microarray Centre, Clinical Genomics Center, University Health Network, Toronto, Ontario, M5G 1L7 Canada.

2 Ontario Cancer Institute, Princess Margaret Hospital, University Health Network, Toronto, Ontario, M5G 2L9 Canada.
Departments of Medical
3 Biophysics and
4 Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, M5G 2L9 Canada.

aAuthor for correspondence. Fax 416-946-2065; e-mail jeremy.squire{at}utoronto.ca.

Molecular diagnostics is a rapidly advancing field in which insights into disease mechanisms are being elucidated by use of new gene-based biomarkers. Until recently, diagnostic and prognostic assessment of diseased tissues and tumors relied heavily on indirect indicators that permitted only general classifications into broad histologic or morphologic subtypes and did not take into account the alterations in individual gene expression. Global expression analysis using microarrays now allows for simultaneous interrogation of the expression of thousands of genes in a high-throughput fashion and offers unprecedented opportunities to obtain molecular signatures of the state of activity of diseased cells and patient samples. Microarray analysis may provide invaluable information on disease pathology, progression, resistance to treatment, and response to cellular microenvironments and ultimately may lead to improved early diagnosis and innovative therapeutic approaches for cancer.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
M. J. Duffy
Predictive Markers in Breast and Other Cancers: A Review
Clin. Chem., March 1, 2005; 51(3): 494 - 503.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Maekawa, T. Nagaoka, T. Taniguchi, H. Higashi, H. Sugimura, K. Sugano, H. Yonekawa, T. Satoh, T. Horii, N. Shirai, et al.
Three-Dimensional Microarray Compared with PCR-Single-Strand Conformation Polymorphism Analysis/DNA Sequencing for Mutation Analysis of K-ras Codons 12 and 13
Clin. Chem., August 1, 2004; 50(8): 1322 - 1327.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Marchetti, F. Barassi, C. Martella, A. Chella, S. Salvatore, A. Castrataro, F. Mucilli, R. Sacco, and F. Buttitta
Down Regulation of High in Normal-1 (HIN-1) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome
Clin. Cancer Res., February 15, 2004; 10(4): 1338 - 1343.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
E. Floyd and T. M. Mcshane
Development and Use of Biomarkers in Oncology Drug Development
Toxicol Pathol, January 1, 2004; 32(1_suppl): 106 - 115.
[Abstract] [PDF]


Home page
Genes Dev.Home page
N. A. Faustino and T. A. Cooper
Pre-mRNA splicing and human disease
Genes & Dev., February 15, 2003; 17(4): 419 - 437.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.